LP
PGEN icon

LMR Partners’s Precigen PGEN Stock Holding History

LMR Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-53,230
Closed -$77.2K – 1260
2024
Q1 		$77.2K Hold
53,230
– – ﹤0.01% 943
2023
Q4 		$71.3K Buy
53,230
+3,108
+6% +$3.65K ﹤0.01% 780
2023
Q3 		$71.2K Hold
50,122
– – ﹤0.01% 702
2023
Q2 		$57.6K Sell
50,122
-3,108
-6% -$3.67K ﹤0.01% 653
2023
Q1 		$56.4K Buy
+53,230
New +$76.7K ﹤0.01% 968

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LMR Partners's PGEN Position: Q2 2024 in Review

LMR Partners sold out of Precigen (PGEN) in Q2 2024, closing a stake of 53,230 shares — an estimated $77.2K sold.

LMR Partners first reported a position in PGEN in Q1 2023 and held it in 5 quarters. The position peaked at $77.2K in Q1 2024. 130 funds tracked by Wall St. Rank hold PGEN as of Q2 2024.

  • LMR Partners reported no remaining Precigen position as of Q2 2024 after selling out during the quarter.
  • LMR Partners sold 53,230 Precigen shares in Q2 2024, an estimated $77.2K.
  • LMR Partners first reported a position in Precigen in Q1 2023 and held it in 5 quarters.
  • LMR Partners's Precigen position peaked at $77.2K in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Precigen as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.